Please assess the completion status of the following clinical trial:

Trial Title: An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must have presbyopia.~Exclusion Criteria:~Subjects must not:~* Have any contraindications to the study medications or diagnoses that would confound the study.

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- CSF-1 (Type: EXPERIMENTAL): One drop bilaterally twice daily for approximately 2 weeks.
- Vehicle (Type: PLACEBO_COMPARATOR): One drop bilaterally twice daily for approximately 2 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).